Ochsner Health brings innovation and diverse capabilities to the fight against cancer. Combining clinical expertise, research leadership and a patient-centered culture, Ochsner’s multidisciplinary approach improves outcomes for thousands of cancer patients each year.
For New Orleans Saints yoga instructor and cancer survivor Jessica Huneycutt, Ochsner’s diverse team of clinicians provided superior care that’s helped her achieve victory over breast cancer.
Ochsner screened 181,317 people for breast, cervical, lung and colorectal cancer in 2019.
Ochsner and Color Genomics announced a fully digital population health pilot program to proactively identify patients at higher risk for certain hereditary cancers.
Our new infusion facility at Ochsner Medical Center — Kenner is the only site in Louisiana to offer Peptide Receptor Radionuclide Therapy (PRRT) for patients suffering from neuroendocrine tumors.
Ochsner and LSU Health Shreveport scientists are participating in collaborative research projects on colon cancer and non-alcoholic steatohepatitis to make additional clinical trials available to North Louisiana patients.
The Ochsner Cancer Institute provides more than 150 clinical trials, many of which are unique to Ochsner and the Gulf South region. Ochsner’s portion of a $13 million group grant from the National Cancer Institute will expand our clinical trials network with an emphasis on minority and underserved cancer patients.
The Gayle and Tom Benson Cancer Center has again been granted Three-Year Accreditation from The Commission on Cancer (CoC), a quality program of the American College of Surgeons. Ochsner has been continuously CoC-accredited since 1986.